TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/18/18 16:31 | 4/16/18 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Zucconi Theodore Daniel | GA | D | M.d | 4 | 0.8900 | 0 | 4 | 1 | D | ||||||||||||||||
4/18/18 16:31 | 4/16/18 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Zucconi Theodore Daniel | GA | D | S.d | -14 | 3.58 | 0 | -4 | -79 | 1 | D | |||||||||||||||
5/24/17 09:39 | 5/23/17 | GALT | Galectin Therapeutics Inc | NV | Health | Drug | Pharmaceutical Preparations | Zucconi Theodore Daniel | GA | D | P | 2 | 2.27 | 0 | 1 | 999% | 1 | D | |||||||||||||||
3/28/11 15:45 | 3/24/11 | PRWP | Pro Pharmaceuticals Inc | NV | Health | Drug | Pharmaceutical Preparations | Zucconi Theodore Daniel | MA | D | M.d | 85 | 0.2300 | 0 | 370 | 384 | 466 | D | |||||||||||||||
9/23/08 11:26 | 9/19/08 | PRW | Pro Pharmaceuticals Inc | NV | Health | Drug | Pharmaceutical Preparations | Zucconi Theodore Daniel | MA | DO | P | P | 0 | 0.2254 | 0 | 2 | 0 | D | |||||||||||||||
9/22/08 17:22 | 9/18/08 | PRW | Pro Pharmaceuticals Inc | NV | Health | Drug | Pharmaceutical Preparations | Zucconi Theodore Daniel | MA | DO | P | P | 2 | 0.2221 | 0 | 9 | 4 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |